(Q74264791)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472729%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Paraoxonase producing PON1 gene M/L55 polymorphism is related to autopsy-verified artery-wall atherosclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472729%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

R Malin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472729%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

O Järvinen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472729%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

T Sisto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472729%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

T Koivula

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472729%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

T Lehtimäki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472729%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472729%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472729%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472729%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472729%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

301-307

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472729%20AND%20SRC:MED&resulttype=core&format=json

Atherosclerosis — An Inflammatory Disease

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

The pathogenesis of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

A critical look at the evidence for the oxidation of LDL in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

HDL, its enzymes and its potential to influence lipid peroxidation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

The molecular basis of the human serum paraoxonase activity polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

Genetic polymorphism of paraoxonase and the risk of coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

Atherosclerosis of the Internal Mammary Artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

The paraoxonase Gln-Arg 192 polymorphism in subjects with ischaemic heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

Serum arylesterase (paraoxonase) activity following myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality. The FINMONICA MI Register Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900728-0

10.1016/S0021-9150(00)00728-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472729%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference